Suchergebnisse - "Sun, Ryan"

PubPharm (5)

1

Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?

enthalten in: JAMA oncology | 2024

von Sun, R. | Wei, L.

2

Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Parseghian, C. | Sun, R. | Woods, M. | +16

3

Quantifying Clinical Utility of Adjuvant Abemaciclib in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy

enthalten in: JAMA oncology | 2022

von Sun, R. | Wei, L.

CommentOn: JAMA Oncol. 2022 Aug 1;8(8):1190-1194. - PMID 35653145

4

Analysis of Overall Survival Benefit of Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer

enthalten in: JAMA oncology | 2020

von Sun, R. | Kim, D. | Wei, L.

CommentOn: JAMA Oncol. 2019 Sep 29;:null. - PMID 31563959

5

Powerful gene set analysis in GWAS with the Generalized Berk-Jones statistic

enthalten in: PLoS genetics | 2019

von Sun, R. | Hui, S. | Bader, G. | +2

1
[1]